Atara lays off more staff this year despite FDA lifting clinical hold
Atara Biotherapeutics continues to salami slice its head count, this time laying off 30% of what remains of its workforce.
Atara Biotherapeutics continues to salami slice its head count, this time laying off 30% of what remains of its workforce.
